MIMETAS’ Post

The future of cell culture and human-relevant screening is here. You will not want to miss this #SLAS2024 talk with Oksana Sirenko of Molecular Devices on their revolutionary new CellXpress.ai Automated Cell culture system. See more: #DanaherLifeSciences #organoids #CellXpress.ai #3DBiology #AIML

📢 It’s almost time! Join our tutorial today at 12:00 PM EST at #SLAS2024 as we formally introduce you to the revolutionary new CellXpress.ai™ Automated Cell Culture System. Experts will discuss why the majority of drugs fail in the later stages of the drug development pipeline, how organoids improve this process, and why their adoption as a primary screening method isn’t more widespread. In addition, they’ll discuss #TheFutureOfCellCulture and how labs can achieve the confidence in experimental outcomes to make key decisions sooner, achieve milestones faster, and get to clinic earlier with lower attrition rates. This session is sure to provide an engaging and in-depth discussion of advanced tissue modeling and assaying you won’t want to miss! https://bit.ly/3vGYZ8N #cellculture #3dimaging #automatedlab #labautomation #machinelearning #organoidmodels #highcontentscreening #CellXpressAI

🚀 New customer case study alert! 🚀 🌐💡The recent work of Valentina Paloschi and her collaborators showcasing Fluigent’s Microfluidic Flow Control System is truly groundbreaking! 🩸By ingeniously creating an Artery-on-chip model, they've successfully replicated the structure of medium-to-large size arteries and deciphered their response to hemodynamic forces. 💊The AoC model not only mimics arteries but also serves as an advanced platform for predictive drug testing, offering insights into the effects of therapeutic agents used in preclinical studies! 🔍Read more about this exciting research here: https://bit.ly/3UT1oaE #Microfluidics #BiotechInnovation #DrugDiscovery #ScienceAdvancement

Can AlphaFold Models be Used for Structure-based drug design? In practice, not yet. Especially for novel targets as needed in antibiotic drug discovery.

Drug discovery and development rely heavily on In vitro study with human 3D tissue model. Read the infographic below to understand the concept and its application field. Learn more: https://lnkd.in/gkanbwWy

Phenotypic changes in cell models hold the key to unlocking critical insights for drug discovery and development. At Ncardia, we leverage High Content Imaging (HCI) to combine iPSC-derived healthy and diseased models with consistent HCI assays, empowering drug developers with faster decision-making and heightened confidence in their discoveries. https://lnkd.in/eHct6KMM #DrugDiscovery #HCI #Highcontentimaging

Introducing LENSᵃⁱ™ in-silico Epitope Binning: Transforming early lead selection in #drugdiscovery Experience our advanced in-silico #epitopebinning that has recently been validated in wet lab experiments. With this innovative technology, researchers can now efficiently evaluate lead candidate pools. Our proven technology matches wet lab binning methods with precision and accuracy, requiring only protein sequences—no need for physical material production. This breakthrough empowers efficient and effective drug discovery. Explore further. https://lnkd.in/eWcXuKzv #AI #InSilico #Antibodies #Biotherapeutics IPA (ImmunoPrecise Antibodies)

Interested in learning about the first ever large-scale phenotypic Organ-on-a-Chip screen? Check out our whitepaper! 🔄 Our detailed report delves into a 1546 compound screen on a 3D angiogenic sprouting assay using the OrganoPlate® as a high-throughput screening tool. Learn how image-based phenotypic screening provides high-resolution insights, generating selective hits and novel biological understanding. 📥 Download the whitepaper now to witness the convergence of cutting-edge technology and advanced screening methodologies. Deepen your understanding on how successful implementation of Organ-on-a-Chip Technology in large-scale phenotypic screening opens new possibilities for the discovery of groundbreaking drugs.: https://lnkd.in/eQDn3fSC #Highthrouhputscreening #phenotypicscreening #organonachip